Bromberg J, Issa S, Bukanina K, et al. Effect of Rituximab in Primary Central Nervous System Lymphoma – results of the Randomized Phase III HOVON 105/ALLG NHL 24 Study. ASH 59th Annual Meeting & Exhibition, abstract 582.
Epcoritamab en tislelizumab in de sluis geplaatst
nov 2023 | Lymfoom, Maag-darm-leveroncologie